Klotho Neurosciences, Inc.
KLTO
$0.7488
$0.068810.12%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 318.15% | 136.16% | 1,572.72% | 2,220.86% | 61.93% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 378.49% | 136.16% | 1,572.72% | 2,220.86% | 61.93% |
Operating Income | -378.49% | -136.16% | -1,572.72% | -2,220.86% | -61.93% |
Income Before Tax | -806.38% | -232.44% | -1,534.23% | -1,953.71% | -70.80% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -806.38% | -232.44% | -1,534.23% | -1,953.71% | -70.80% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -806.38% | -232.44% | -1,534.23% | -1,953.71% | -70.80% |
EBIT | -378.49% | -136.16% | -1,572.72% | -2,220.86% | -61.93% |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -318.75% | -82.88% | -803.57% | -1,766.32% | -64.57% |
Normalized Basic EPS | -318.33% | -82.37% | -813.46% | -1,746.67% | -65.14% |
EPS Diluted | -318.75% | -82.88% | -659.00% | -1,700.00% | -64.57% |
Normalized Diluted EPS | -318.33% | -82.37% | -813.46% | -1,746.67% | -65.14% |
Average Basic Shares Outstanding | 116.55% | 81.91% | 79.92% | 10.30% | 3.63% |
Average Diluted Shares Outstanding | 116.55% | 81.91% | 79.92% | 10.30% | 3.63% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |